Clinical Trial

Investigating the Effects of Green Tea on Blood Viscosity

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 27, 2024 (before its estimated May 2025 completion). Its status may not reflect the trial's current state.
Summary
A diet high in flavonoids is becoming more established as beneficial to human health. Recent data suggest that the regular consumption of flavanols can reduce the numbers of deaths by cardiovascular disease at a population level. The mechanisms for these reductions in deaths by cardiovascular disease are still debated and little is known about their impacts on factors affecting blood viscosity. The metabolism of flavanols is complex, with different metabolites being predominant in the blood at different time points. Therefore, in this study, we will investigate the effects of green tea, a well-known source of flavanols, on blood viscosity at different time points. This will be assessed in healthy individuals with no history of cardiovascular disease aged 65+ years old. Blood viscosity will be measured before, and 2hours and 8hours after the consumption of green tea.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-12-13.
Trial Details
NCT Number NCT06740448
Lead Sponsor University of Reading
Collaborators: Biotechnology and Biological Sciences Research Council, Royal Berkshire NHS Foundation Trust
Conditions Cardiovascular Disease
Enrollment 35 participants
Start Date 2025-01
Primary Completion 2025-05 (estimated)
Study Completion 2025-05 (estimated)
Updated on ClinicalTrials.gov 2024-12-27